Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—D.D.C.: Advocacy groups fail to halt Medicare hemp program
    • ADMINISTRATION OF FDC ACT—NOTICES: Hepatitis Delta Virus Diseases not designated as an addition to the current list of tropical diseases
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—PROPOSED RULES: Medicaid managed care state directed payments, Medicaid fee-for service targeted Medicaid practitioner payments proposed
    • ANTI-KICKBACK PROHIBITION—OIG ADVISORY OPINIONS: Low risk of fraud, abuse in arrangement providing free supplemental cancer screening report
    • BILLING AND CODING—DAB DECISIONS: Gap in medical practice’s Medicare billing privileges upheld by administrative law judge
    • CONTROLLED SUBSTANCES—FINAL RULES: Temporary placement of 2- fluorodeschloroketamine in Schedule I
    • COSMETICS—D.N.J.: Consumers lacked standing where they failed to show that they relied upon manufacturer’s representations
    • EXPERT INSIGHTS—CMS "Crackdown On Fraud" Continues With Nationwide Six-Month Moratoria On New Medicare Enrollments For Hospices And Home Health Agencies
    • GENERAL HEALTH CARE NEWS—S.D. Tex.: Lack of jurisdiction argument fails, innocent seller rule applies
    • PREEMPTION OF STATE LAW—D. Md.: Woman injured by degraded brain implant has no state law cause of action
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—FINAL RULES: Temporary placement of 2- fluorodeschloroketamine in Schedule I, (May 26, 2026)

    By WK Editorial Staff

    The DEA based its action on a finding that placing 2-fluorodeschloroketamine in schedule I is necessary to avoid an imminent hazard to public safety.

    The Drug Enforcement Administration (DEA) issued a temporary order to schedule 2-(2- fluorophenyl)-2- ...

    By WK Editorial Staff

    The DEA based its action on a finding that placing 2-fluorodeschloroketamine in schedule I is necessary to avoid an imminent hazard to public safety.

    The Drug Enforcement Administration (DEA) issued a temporary order to schedule 2-(2- fluorophenyl)-2- (methylamino)cyclohexan-1-one (commonly known as 2- fluorodeschloroketamine or 2–FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. The order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle this substance (Final Rule, 91 Fed. Reg. 30204 (May 22, 2026)).

    Dates. The temporary order is effective May 22, 2026, until May 22, 2028.

    FederalRegisterIssuances: FinalRules ControlledNews SafetyNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use